Time to sell...nothing left here. Without PAT-SM6 there is no clinical value in the company...everything is far behind. So, this is now an early preclinical company with no reliable solution on how to make their only products. With cash running out, where are they going to go?????????
- Forums
- ASX - By Stock
- PAB
- Ann: Manufacturing Update - Clinical Trial Remains on Hold
Ann: Manufacturing Update - Clinical Trial Remains on Hold, page-4
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 26519870 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 7889760 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 26519870 | 0.004 |
30 | 26629632 | 0.003 |
16 | 21570001 | 0.002 |
11 | 48751998 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 7889760 | 12 |
0.006 | 9510918 | 10 |
0.007 | 1525381 | 3 |
0.008 | 75000 | 1 |
0.010 | 46000 | 1 |
Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online